Trade AstraZeneca ^AZN

AstraZeneca Now Acquired Biotech Company EsoBiotec, for $1B

Is AstraZeneca (AZN) the Best European Stock to Buy According to Billionaires?

Primecap Management Co. CA Trims Holdings in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Twin Tree Management LP

Wealthfront Advisers LLC Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)

Amundi Reduces Position in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca (AZN) Gets a Buy from Barclays | Markets Insider

Diverse ancestral representation improves genetic intolerance metrics

FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results | The Manila Times

FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results | Taiwan News | Mar. 18, 2025 04:05

Biotech Alert: Searches spiking for these stocks today | Markets Insider

AstraZeneca Acquires EsoBiotec; Strikes Deal with Alteogen to Develop Oncology Therapies

AstraZeneca (AZN) Receives a Buy from Bernstein | Markets Insider

H.C. Wainwright says competitor data builds optimism for NextCure's LNCB74 | Markets Insider

Goldman Sachs Sticks to Its Buy Rating for AstraZeneca (AZN) | Markets Insider

IgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals | Morningstar

AstraZeneca (AZN) Gets a Buy from UBS | Markets Insider

Trending tickers: Nvidia, Berkshire Hathaway, Baidu, QinetiQ and AstraZeneca

Nicholas Company Inc. Acquires 171,199 Shares of AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca partners with Alteogen to develop subcutaneous options for its Onco assets

M&A News: AstraZeneca Seals Belgian Firm EsoBiotec Deal to Boost Cell Therapy | Markets Insider

AstraZeneca announces Imfinzi approved in European Union | Markets Insider

AstraZeneca announces eneboparatide met primary endpoint in Phase III trial | Markets Insider

AstraZeneca enters license agreement with Alteogen for ALT-B4 | Markets Insider

AstraZeneca to acquire EsoBiotec for $425M upfront | Markets Insider

AstraZeneca to buy EsoBiotec for up to $1 billion - The Hindu BusinessLine

AstraZeneca Buys Belgian EsoBiotec for Up to $1 Billion to Boost Cell-Therapy Portfolio | Morningstar

AstraZeneca to buy EsoBiotec for up to US$1 billion - The Business Times

AstraZeneca to Buy EsoBiotec SA for Total Value of up to $1B

EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition

European markets set to open the new trading week higher; German debt reform vote ahead

AstraZeneca: EU Approves Imfinzi As First And Only Immunotherapy For LS - Small Cell Lung Cancer

AstraZeneca To Buy Belgium's Cell Therapy Firm EsoBiotec In Up To $1 Bln Deal

Eneboparatide Met Primary Endpoint of Normalising Serum Calcium in Adults with Hypoparathyroidism at 24 weeks in CALYPSO Phase III Trial - Drugs.com MedNews

AZN's Imfinzi Gets EU Nod for Limited-Stage Small-Cell Lung Cancer - March 17, 2025 - Zacks.com

AstraZeneca buys EsoBiotec for $1 B to advance cell therapy ambition

Astrazeneca Pharma India Ltd Stock Price: Astrazeneca Phar Share Price Today | India Infoline

AZN to Acquire EsoBiotec for $1B to Develop In Vivo Cell Therapies - March 17, 2025 - Zacks.com

Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer

Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial

Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results

Luveltamab Tazevibulin Produces Responses in Platinum-Resistant Ovarian Cancer With Low/Medium FRα Expression

Updated MIRASOL Data Support Mirvetuximab Soravtansine as SOC for FRα+ Platinum-Resistant Ovarian Cancer

Nicholas Company Inc. Raises Stock Position in AstraZeneca PLC (NASDAQ:AZN)

Clearstead Trust LLC Has $289,000 Holdings in AstraZeneca PLC (NASDAQ:AZN)

Zevin Asset Management LLC Grows Position in AstraZeneca PLC (NASDAQ:AZN)

AGF Management Ltd. Cuts Stock Position in AstraZeneca PLC (NASDAQ:AZN)

Parnassus Investments LLC Boosts Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca (LON:AZN) Stock Crosses Above 200 Day Moving Average - What's Next?

AstraZeneca's Portfolio and Pipeline Support Solid Long-Term Growth | Morningstar

AstraZeneca and Erin Andrews team up to inspire fans to Get Body Checked Against Cancer

AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Avantax Advisory Services Inc.

Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials

Cellectis reports Q4 EPS (64c) vs (17c) last year | Markets Insider

Sage Mountain Advisors LLC Decreases Stock Position in AstraZeneca PLC (NASDAQ:AZN)

Tolerance and effectiveness of inhaled antibiotics at standard or low doses in COPD patients with chronic Pseudomonas aeruginosa bronchial infection

First insights and future research perspectives from the sarcoidosis registry at the Medical University of Vienna

Delaware High Court Weighs Reviving AstraZeneca Shareholder Suit

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)

Natural Investments LLC Purchases New Position in AstraZeneca PLC (NASDAQ:AZN)

Davis R M Inc. Invests $268,000 in AstraZeneca PLC (NASDAQ:AZN)

Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know - March 12, 2025 - Zacks.com

Lynparza and Breast Cancer: Study Finds Reduced Recurrence Risk in HR-Positive Patients

15,663 Shares in AstraZeneca PLC (NASDAQ:AZN) Purchased by Sowell Financial Services LLC

AstraZeneca PLC (NASDAQ:AZN) Shares Sold by PNC Financial Services Group Inc.

Victory Capital Management Inc. Boosts Stock Position in AstraZeneca PLC (NASDAQ:AZN)

Arvinas, Pfizer Report Positive Topline Data From Phase 3 VERITAC-2 Study

Astrazeneca divulges new antibody-drug conjugates | BioWorld

IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe - March 11, 2025 - Zacks.com

A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer

Sound View Wealth Advisors Group LLC Raises Position in AstraZeneca PLC (NASDAQ:AZN)

6,500 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by American Assets Inc.

Morton Community Bank Buys 2,405 Shares of AstraZeneca PLC (NASDAQ:AZN)

Ionis and AstraZeneca's WAINZUA gets EU approval for ATTRv-PN treatment | Markets Insider

AstraZeneca PLC (NASDAQ:AZN) Position Boosted by Banco Santander S.A.

UBS Keeps Their Buy Rating on AstraZeneca (AZN) | Markets Insider

Argentarii LLC Purchases New Shares in AstraZeneca PLC (NASDAQ:AZN)

HM Payson & Co. Decreases Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)

Ionis Pharma Reports Approval Of WAINZUA In The EU - Quick Facts

AstraZeneca Share Price Today, AstraZeneca Stock Price Live NSE/BSE, Share Price Insights

Scientists link new gene to high Parkinson's disease risk

MORPHEUS-Liver provides a way forward in expanding the immunotherapy options for hepatocellular carcinoma

HER2+ Gastric Cancer Market to Witness Upsurge in Growth During the Forecast Period (2024-2034), Examine DelveInsight | ABNewswire

Dorsey & Whitney Trust CO LLC Buys 189 Shares of AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Sound View Wealth Advisors Group LLC

American Assets Inc. Buys Shares of 6,500 AstraZeneca PLC (NASDAQ:AZN)

E Fund Management Co. Ltd. Purchases 1,488 Shares of AstraZeneca PLC (NASDAQ:AZN)

Axis Wealth Partners LLC Invests $269,000 in AstraZeneca PLC (NASDAQ:AZN)

Charles Schwab Investment Management Inc. Reduces Position in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Charles Schwab Investment Management Inc.

Naviter Wealth LLC Sells 1,376 Shares of AstraZeneca PLC (NASDAQ:AZN)